Buying authority will continue to shift upstream as presidents, provosts, and CFOs require program-level visibility before approving spend, reducing the effectiveness of selling exclusively through functional or departmental buyers.

Vendors that cannot map their value to specific program economics will see increased deal friction, particularly where enrollment, aid eligibility, and margin are being evaluated together rather than in isolation.

Product roadmaps will face pressure from institutional research, finance, and academic leadership to support defensible program-level analysis rather than aggregate dashboards designed for marketing or reporting convenience.

Sales cycles will increasingly hinge on whether solutions help institutions make keep, fix, or exit decisions for marginal programs, not on whether they improve performance at the margin.

Partnerships and integrations that surface outcomes data alongside financial and aid exposure will matter more to CIOs and provost offices than incremental feature depth within a single system.

Vendors positioned as growth enablers without a credible role in risk containment will find themselves deferred even in institutions that remain otherwise well resourced.

Near-term budget shock has been avoided, which means VPRs and CFOs are less likely to rush into defensive restructurings and more likely to continue evaluating vendors on long-term fit rather than emergency cost relief.

Research administration and compliance teams will retain spending discretion, but procurement conversations will increasingly probe whether tools strengthen the defensibility of indirect cost claims rather than simply supporting throughput.

Vendors pitching efficiency gains as a hedge against overhead compression will need to recalibrate, as institutional leaders now have more time to assess whether those gains justify disruption.

Product leaders should expect heightened scrutiny from sponsored research offices around audit readiness and documentation, as institutions remain aware that future policy attempts could reintroduce pressure through different mechanisms.

Sales cycles will still involve legal and finance stakeholders, but with a more measured tone focused on resilience and compliance credibility rather than immediate budget substitution.

Institutions with large NIH portfolios are likely to defer major platform changes, favoring incremental enhancements and integrations that do not jeopardize existing cost recovery models.

Large public research universities are signaling that AI is now a core academic competency, which will pull CIOs, provosts, and deans into coordinated infrastructure decisions rather than allowing colleges to improvise independently.

Vendors will increasingly be evaluated on whether their platforms can support program-level implementation plans and assessment evidence, not just institution-wide AI statements or generic tooling.

LMS, ERP, and data vendors should expect pressure to demonstrate how AI capabilities integrate cleanly into existing curricular workflows without creating parallel systems that faculty must manage separately.

Buying decisions will shift toward solutions that enable consistency across colleges while still allowing disciplinary variation, a balance that academic leadership will scrutinize closely.

Institutions watching Ohio State and Purdue are likely to delay commitments until they see operational proof, shortening the window for speculative pilots but opening longer-term opportunities for scalable infrastructure.

Vendors positioning AI as an add-on feature rather than as something that can be governed, assessed, and sustained across cohorts will struggle to stay relevant in these conversations.

CIOs and CFOs will increasingly evaluate ERP and SIS decisions through a concentration-risk lens, which raises the bar for competitors and adjacent vendors to articulate how they coexist with or hedge against a dominant core platform.

Pricing discussions will become more strategic and less transactional, as institutions recognize reduced leverage over a consolidated provider and look for alternative areas where vendors can restore balance or optionality.

Product leaders should expect heightened scrutiny around roadmaps and interoperability, particularly from registrars and data governance teams concerned about lock-in, migration risk, and future flexibility.

AI and analytics vendors will find doors opening and closing simultaneously, as consolidation simplifies data access in some cases while tightening control over integration points in others.

Sales cycles will increasingly involve enterprise architecture and resilience conversations, not just functional fit, especially at systems and large publics with limited tolerance for single points of failure.

Vendors positioned as complements to core administrative systems rather than substitutes will need to demonstrate durability and independence to remain credible partners over multi-year horizons.